|4Jul 7, 4:16 PM ET

D'Angio Paul 4

4 · NexImmune, Inc. · Filed Jul 7, 2023

Insider Transaction Report

Form 4
Period: 2023-07-05
D'Angio Paul
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-07-05+44,98344,983 total
    Exercise: $0.29From: 2024-07-05Exp: 2033-07-04Common Stock (44,983 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary

    4